# L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia

> **NCT03542812** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 16 (actual)

## Conditions studied

- Infant,Premature
- Bronchopulmonary Dysplasia
- Pulmonary Hypertension

## Interventions

- **DRUG:** L-Citrulline

## Key facts

- **NCT ID:** NCT03542812
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-30
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The study stopped enrollment prior to the initially projected 18 subjects per phase due to lack of funding to continue to recertify the drug and because an adequate number of subjects were enrolled for each phase to analyze pharmacokinetics.
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542812, "L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03542812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*